Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125811371 | 12581137 | 1 | I | 201606 | 20160718 | 20160721 | 20160721 | EXP | FR-AFSSAPS-LL20161140 | FR-GLAXOSMITHKLINE-FR2016GSK103155 | GLAXOSMITHKLINE | 49.00 | YR | M | Y | 0.00000 | 20160721 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125811371 | 12581137 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | UNK | Y | 20241 | ||||||||||
| 125811371 | 12581137 | 2 | C | URBANYL | CLOBAZAM | 1 | 50 MG, TID | U | 0 | 50 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125811371 | 12581137 | 1 | Partial seizures |
| 125811371 | 12581137 | 2 | Partial seizures |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125811371 | 12581137 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125811371 | 12581137 | Headache | |
| 125811371 | 12581137 | Hyponatraemia | |
| 125811371 | 12581137 | Nausea | |
| 125811371 | 12581137 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125811371 | 12581137 | 1 | 20160609 | 20160616 | 0 | |
| 125811371 | 12581137 | 2 | 20160609 | 0 |